Antivir Ther

1. YOUNG J, Lawler PR, Moodie EEM, Bucher HC, et al
   It's about time: The association between abacavir and cardiovascular disease.
   Antivir Ther. 2026;31:13596535261438178.
   

   >> Share

   
   

   
   Clin Infect Dis

2. KILLANDER MOLLER I, Wagner P, Brannstrom J, Backdahl T, et al
   Renal and Cardiovascular Complications Following Type 2 Diabetes Mellitus in People With and Without HIV: Data from Cohort Study on Morbidity and HIV in Sweden (COSMOHS) between 2010-2024.
   Clin Infect Dis. 2026 Apr 18:ciag261. doi: 10.1093.
   

   >> Share

   
   

   
   HIV Med

3. SANCHEZ-CANO JG, Munoz-Echeverria L, Casco-Garcia M, Moreno-Nunez L, et al
   Twice-daily bictegravir during rifampicin-based tuberculosis therapy: A pragmatic alternative.
   HIV Med. 2026 Apr 20. doi: 10.1111/hiv.70245.
   

   >> Share

   
   

   
   J Med Virol

4. GUNDESLIOGLU OO, Tapac N, Kilinc F, Kibar F, et al
   Chronic Hepatitis B in Children Admitted to a Tertiary Hospital in Turkiye: A 23-Year Observational Study.
   J Med Virol. 2026;98:e70939.
   

   >> Share

   
   

   
   N Engl J Med

5. LANE HC, Fauci AS
   Same Pill, Different Impact - Reassessing the Efficacy of Nirmatrelvir-Ritonavir.
   N Engl J Med. 2026;394:1649-1650.
   

   >> Share

   
   
6. BUTLER CC, Pinto AD, Harris V, Holmes J, et al
   Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk Outpatients.
   N Engl J Med. 2026;394:1583-1594.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share